Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003117149 | SCV003796158 | uncertain significance | Metachromatic leukodystrophy | 2021-08-31 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with threonine at codon 152 of the ARSA protein (p.Ser152Thr). The serine residue is highly conserved and there is a small physicochemical difference between serine and threonine. This variant is present in population databases (rs754595975, ExAC 0.002%). This variant has not been reported in the literature in individuals affected with ARSA-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004765751 | SCV005380582 | uncertain significance | not specified | 2024-08-19 | criteria provided, single submitter | clinical testing | |
Gelb Laboratory, |
RCV003117149 | SCV005046630 | not provided | Metachromatic leukodystrophy | no assertion provided | in vitro |